Prospect Partners teamed with management to recapitalize Navix Diagnostix, Inc. (“Navix”) in August, 2010.

Navix is a leading provider of outsourced cardiovascular diagnostic services to hospitals, multi-specialty practices, vascular surgeons, and cardiologists throughout New England and the Mid-Atlantic states. Navix partners with healthcare providers to grow their non-invasive vascular labs in order to diagnose, and manage peripheral vascular disease, a pre-cursor to strokes and coronary heart disease.